S&P 500: 669.03 +1.0% NASDAQ 100: 600.38 +1.1% Dow Jones: 470.30 +0.8%

Private Capital’s MRK Holdings & Trades

First Buy
Q3 2022
Duration Held
7 Quarters
Largest Add
Q3 2022
+5,789 Shares
Current Position
2,325 Shares
$244,730 Value

Private Capital's MRK Position Overview

Private Capital (via Private Capital Management, LLC) currently holds 2,325 shares of Merck & Co., Inc. (MRK) worth $244,730, representing 0.02% of the portfolio. First purchased in 2022-Q3, this short-term holding has been held for 7 quarters.

Based on 13F filings, Private Capital has maintained this position in MRK for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 2,325 shares. Largest reduction occurred in Q1 2023, reducing 3,505 shares.

Analysis based on 13F filings available since 2013 Q2

Private Capital's Merck & Co (MRK) Holding Value Over Time

Track share changes against reported price movement

Quarterly Merck & Co (MRK) Trades by Private Capital

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q4 2025 +2,325 New Buy 2,325 $105.26
Q3 2024 -1,664 Sold Out 0 $0.00
Q2 2024 +2 Add 0.12% 1,664 $123.83
Q1 2024 +1,662 New Buy 1,662 $131.94
Q1 2023 -3,505 Sold Out 0 $0.00
Q4 2022 -2,284 Reduce 39.45% 3,505 $110.95
Q3 2022 +5,789 New Buy 5,789 $86.20

Private Capital's Merck & Co Investment FAQs

Private Capital first purchased Merck & Co., Inc. (MRK) in Q3 2022, acquiring 5,789 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Private Capital has held Merck & Co., Inc. (MRK) for 7 quarters since Q3 2022.

Private Capital's largest addition to Merck & Co., Inc. (MRK) was in Q3 2022, adding 5,789 shares worth $499,000.

According to the latest 13F filing for Q4 2025, Private Capital's firm, Private Capital Management, LLC, owns 2,325 shares of Merck & Co., Inc. (MRK), valued at approximately $244,730.

As of the Q4 2025 filing, Merck & Co., Inc. (MRK) represents approximately 0.02% of Private Capital's publicly disclosed stock portfolio, making it one of their key holdings.

Private Capital's peak holding in Merck & Co., Inc. (MRK) was 5,789 shares, as reported at the end of Q3 2022.